Connor, Clark & Lunn Investment Management (CC&L)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,367
| Closed | -$600K | – | 1744 |
|
|
2023
Q4 | $600K | Buy |
14,367
+3,034
| +27% | +$127K | ﹤0.01% | 993 |
|
|
2023
Q3 | $427K | Buy |
+11,333
| New | +$427K | ﹤0.01% | 1057 |
|
|
2020
Q3 | – | Sell |
-5,623
| Closed | -$374K | – | 1164 |
|
|
2020
Q2 | $374K | Sell |
5,623
-652
| -10% | -$43.4K | ﹤0.01% | 805 |
|
|
2020
Q1 | $384K | Buy |
6,275
+500
| +9% | +$30.6K | ﹤0.01% | 754 |
|
|
2019
Q4 | $508K | Sell |
5,775
-1,700
| -23% | -$150K | ﹤0.01% | 660 |
|
|
2019
Q3 | $564K | Buy |
7,475
+1,175
| +19% | +$88.7K | ﹤0.01% | 658 |
|
|
2019
Q2 | $538K | Sell |
6,300
-650
| -9% | -$55.5K | ﹤0.01% | 709 |
|
|
2019
Q1 | $751K | Sell |
6,950
-2,575
| -27% | -$278K | 0.01% | 587 |
|
|
2018
Q4 | $806K | Sell |
9,525
-3,900
| -29% | -$330K | 0.01% | 593 |
|
|
2018
Q3 | $1.32M | Buy |
13,425
+675
| +5% | +$66.4K | 0.01% | 524 |
|
|
2018
Q2 | $1.48M | Buy |
+12,750
| New | +$1.48M | 0.01% | 536 |
|
|
2016
Q3 | – | Sell |
-5,100
| Closed | -$743K | – | 928 |
|
|
2016
Q2 | $743K | Buy |
+5,100
| New | +$743K | 0.01% | 514 |
|